A connected network of companies and individuals working to promote collaborative development of curated open source R packages for clinical reporting usage in pharma, in a space where previously we would only ever have worked in silos on our own closed source and often duplicative solutions. Adopting shared solutions in this post-competitive space should ultimately ease regulatory review, resulting in bringing new treatments to patients faster.
Disclaimer: Anyone is free to choose any selection of pharmaverse recommended software or those from any other source, as there are many different pathways available. Being listed on our site gives no endorsement of the reliability of any code, it is up to you to assess suitability for your needs. Finally, before using any open source software you should always check the license.
Please see our keynote speech at R/Pharma 2022.
This is governed by our pharmaverse working groups - see our Contribute section of the site for more details. Please reach out to us if you feel a package should be included, provided it offers significantly unique scope compared to the packages already included. You can do this by raising an issue here and choosing our “New package request” template.
While it’s likely in a production use of the packages you will be maintaining your own CRAN-like library within your company, for exploration and development purposes any of the hex logos shown above include a link direct to the GitHub repo of each package. We also host the packages, and their dependencies, in a CRAN-like server on R-universe. Please follow this link to see how to point add this CRAN-like server to your library list in R. See information at Get packages
No, but we currently are connecting with several companies and industry working groups (see Other Open Sourcing) to assess whether there could be an industry recommended approach to R package validation utilising open source packages. Until we have this, we’d be happy to share our learnings and current strategies in this area from the companies involved in pharmaverse.
|Ari Siggaard Knoph